97 related articles for article (PubMed ID: 27569531)
1. The effects of differences in pspA alleles and capsular types on the resistance of Streptococcus pneumoniae to killing by apolactoferrin.
Mirza S; Benjamin WH; Coan PA; Hwang SA; Winslett AK; Yother J; Hollingshead SK; Fujihashi K; Briles DE
Microb Pathog; 2016 Oct; 99():209-219. PubMed ID: 27569531
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing.
André GO; Politano WR; Mirza S; Converso TR; Ferraz LF; Leite LC; Darrieux M
Microb Pathog; 2015 Dec; 89():7-17. PubMed ID: 26298002
[TBL] [Abstract][Full Text] [Related]
3. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].
Shaper M; Hollingshead SK; Benjamin WH; Briles DE
Infect Immun; 2004 Sep; 72(9):5031-40. PubMed ID: 15321996
[TBL] [Abstract][Full Text] [Related]
4. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae.
Hammerschmidt S; Bethe G; Remane PH; Chhatwal GS
Infect Immun; 1999 Apr; 67(4):1683-7. PubMed ID: 10085004
[TBL] [Abstract][Full Text] [Related]
5. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae.
Daniels CC; Briles TC; Mirza S; Håkansson AP; Briles DE
Microb Pathog; 2006 May; 40(5):228-33. PubMed ID: 16540281
[TBL] [Abstract][Full Text] [Related]
6. Characterization of binding of human lactoferrin to pneumococcal surface protein A.
Håkansson A; Roche H; Mirza S; McDaniel LS; Brooks-Walter A; Briles DE
Infect Immun; 2001 May; 69(5):3372-81. PubMed ID: 11292760
[TBL] [Abstract][Full Text] [Related]
7. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.
Ren B; Szalai AJ; Thomas O; Hollingshead SK; Briles DE
Infect Immun; 2003 Jan; 71(1):75-85. PubMed ID: 12496151
[TBL] [Abstract][Full Text] [Related]
8. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.
Abeyta M; Hardy GG; Yother J
Infect Immun; 2003 Jan; 71(1):218-25. PubMed ID: 12496169
[TBL] [Abstract][Full Text] [Related]
9. Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.
Mirza S; Wilson L; Benjamin WH; Novak J; Barnes S; Hollingshead SK; Briles DE
Infect Immun; 2011 Jun; 79(6):2440-50. PubMed ID: 21422179
[TBL] [Abstract][Full Text] [Related]
10. PspA facilitates evasion of pneumococci from bactericidal activity of neutrophil extracellular traps (NETs).
Martinez PJ; Farhan A; Mustafa M; Javaid N; Darkoh C; Garrido-Sanabria E; Fisher-Hoch SP; Briles DE; Kantarci A; Mirza S
Microb Pathog; 2019 Nov; 136():103653. PubMed ID: 31398527
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a modified opsonophagocytic killing assay for anti-pneumococcal surface protein A antibody.
Kuroda E; Koizumi Y; Piao Z; Nakayama H; Tomono K; Oishi K; Hamaguchi S; Akeda Y
J Microbiol Methods; 2023 Sep; 212():106804. PubMed ID: 37543109
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the simultaneous expression of two PspAs by a clone of capsular serotype 6B Streptococcus pneumoniae.
Crain MJ; Turner JS; Robinson DA; Coffey TJ; Brooks-Walter A; McDaniel LS; Briles DE
Microb Pathog; 1996 Oct; 21(4):265-75. PubMed ID: 8905615
[TBL] [Abstract][Full Text] [Related]
13. Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism.
Senkovich O; Cook WJ; Mirza S; Hollingshead SK; Protasevich II; Briles DE; Chattopadhyay D
J Mol Biol; 2007 Jul; 370(4):701-13. PubMed ID: 17543335
[TBL] [Abstract][Full Text] [Related]
14. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
15. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae.
Hollingshead SK; Becker R; Briles DE
Infect Immun; 2000 Oct; 68(10):5889-900. PubMed ID: 10992499
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types.
McDaniel LS; McDaniel DO; Hollingshead SK; Briles DE
Infect Immun; 1998 Oct; 66(10):4748-54. PubMed ID: 9746574
[TBL] [Abstract][Full Text] [Related]
17. Invasive Streptococcus pneumoniae isolates from Argentinian children: serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity.
Mollerach M; Regueira M; Bonofiglio L; Callejo R; Pace J; Di Fabio JL; Hollingshead S; Briles D;
Epidemiol Infect; 2004 Apr; 132(2):177-84. PubMed ID: 15061491
[TBL] [Abstract][Full Text] [Related]
18. Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae.
Waltman WD; McDaniel LS; Gray BM; Briles DE
Microb Pathog; 1990 Jan; 8(1):61-9. PubMed ID: 2333033
[TBL] [Abstract][Full Text] [Related]
19. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.
Briles DE; Hollingshead SK; King J; Swift A; Braun PA; Park MK; Ferguson LM; Nahm MH; Nabors GS
J Infect Dis; 2000 Dec; 182(6):1694-701. PubMed ID: 11069242
[TBL] [Abstract][Full Text] [Related]
20. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
Lin H; Peng Y; Lin Z; Zhang S; Guo Y
Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
